[go: up one dir, main page]

Prolactin level is significantly elevated in lesional skin of patients with psoriasis

Int J Dermatol. 2011 Jun;50(6):693-6. doi: 10.1111/j.1365-4632.2010.04752.x.

Abstract

Background: Accumulating data point to a potential role of prolactin in the pathogenesis of psoriasis.

Methods: We initiated a study including psoriasis patients (n = 15) and healthy volunteers (n = 15) as controls. Psoriasis area and severity index (PASI) score was evaluated, and prolactin levels in serum and blister fluid were assessed by enzyme-linked immunosorbent assay (ELISA).

Results: Prolactin levels were significantly (P < 0.01) elevated in blister fluid of psoriatic lesional skin. Correlations between PASI score and different serum prolactin levels in lesional and non-lesional skin were insignificant. Significant positive correlations of prolactin level were observed between lesional and non-lesional skin in psoriasis (P < 0.05) and between serum and clinically normal skin in both psoriasis and control subjects (P < 0.05).

Conclusions: Locally produced prolactin may be involved in the pathogenesis of psoriatic lesions.

MeSH terms

  • Adult
  • Blister / metabolism*
  • Case-Control Studies
  • Humans
  • Male
  • Middle Aged
  • Prolactin / blood
  • Prolactin / metabolism*
  • Psoriasis / blood
  • Psoriasis / metabolism*
  • Severity of Illness Index
  • Skin / metabolism
  • Young Adult

Substances

  • Prolactin